Wegovy is the brand name for semaglutide 2.4 mg, a prescription medicine licensed in the UK for weight management in adults with obesity (BMI 30 kg/m) or those who are overweight (BMI 27 kg/m) with at least one weight-related comorbidity
One of our standout treatments is the personalized approach to Semaglutide
With a plasma halflife of roughly two hours, ipamorelin is absorbed and cleared quickly, yet it delivers both immediate and followon GH pulses that promote cell regeneration, leanmass gains, and metabolic vitality (National Cancer Institute) This mechanism triggers a cascade of physiological responses throughout the human body, promoting cellular regeneration without increasing cortisol (National Library of Medicine) or other hormones
Brightens skin from the inside out
3, 2025 (HealthDay News) The weight-loss drug Wegovy may lower the risk of heart attack, stroke or death more than similar medications, according to new research from its maker, Novo Nordisk